The synthetic caged Garcinia xanthone cluvenone induces cell stress and apoptosis and has immune modulatory activity

Molecular Cancer Therapeutics

Volumn 9, Issue 11, 2010, Pages 2869-2878

  Batova, Ayse ^a   Altomare, Diego ^b   Chantarasriwong, Oraphin ^a   Ohlsen, Kari L ^a   Creek, Kim E ^c   Lin, You Chin ^d   Messersmith, Amy ^b   Yu, Alice L ^a,d   Yu, John ^e   Theodorakis, Emmanuel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of South Carolina   (United States)

^d GENOMICS RESEARCH CENTER   (Taiwan)

^e INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CLUVENONE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL STRESS; ENZYME ACTIVATION; GARCINIA; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CELLS; DRUG EVALUATION, PRECLINICAL; GARCINIA; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; MICROARRAY ANALYSIS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; TUMOR CELLS, CULTURED; XANTHONES;

EID: 78649671801     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0517     Document Type: Article

References (40)

1. Ollis WD, Redman BT, Sutherland IO, Jewers K. The constitution of bronianone. J Chem Soc Chem Commun 1969:879-80.
2. Kumar P, Baslas RK. Phytochemical and biological studies of the plants of the genus Garcinia. Herb Hung 1980;19:81-91.
3. Asano J, Chiba K, Tada M, Yoshii T. Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry 1996;41:815-20.
4. Zhang H-Z, Kasibhatla S, Wang Y, et al. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg Med Chem 2004;12:309-17.
5. Zhao L, Guo Q-L, You Q-D, Wu Z-Q, Gu H-Y. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull 2004;27:998-1003.
6. Yang Y, Yang L, You QD, et al. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett 2007;256:259-66.
7. Guo QL, You QD, Wu ZQ, Yuan ST, Zhao L. General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol Sin 2004;25:769-74.
8. Qiang L, Yang Y, You Q-D, et al. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study. Biochem Pharmacol 2008;75:1083-92.
9. Zhou ZT, Wang JW. Phase I human tolerability trial of gambogic acid. Chin J New Drugs 2007;16:79-83.
10. Tisdale EJ, Vong BG, Li H, Kim SH, Chowdhury C, Theodorakis EA. Total synthesis of Secolateriflorone. Tetrahedron 2003;59:6873-87.
11. Tisdale EJ, Slobodov I, Theodorakis EA. Unified synthesis of caged Garcinia natural products based on a site-selective Claisen/Diels-Alder/Claisen rearrangement. Proc Nat Acad Sci U S A 2004;101:12030-5.
12. Batova A, Lam T, Wascholowski V, Yu A, Giannis A, Theodorakis EA. Synthesis and evaluation of caged Garcinia xanthones. Org Biomol Chem 2007;5:494-500.
13. Chantarasriwong O, Cho WC, Batova A, et al. Evaluation of the pharmacophoric motif of the caged Garcinia xanthones. Org Biomol Chem 2009;7:4886-94.
14. Draghici S, Khatri P, Tarca AL, et al. A systems biology approach for pathway level analysis. Genome Res 2007;17:1537-45.
15. Batova A, Shao LE, Diccianni MB, et al. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines. Blood 2002;100:3319-24.
16. Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities. J Med Chem 2002;45:818-40.
17. Covelle DG, Wallquist A, Huang R, Thanki N, Rabow AA, Lu X-J. Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases. Proteins 2005;59:403-33.
18. Wu ZQ, Guo Q-L, You Q-D, Zhao L, Gu H-Y. Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol Pharm Bull 2004;27:1769-74.
19. Yu J, Guo Q-L, You Q-D, et al. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother Pharmacol 2006;58:434-43.
20. Owuor ED, Kong AN. Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol 2002;64:765-70.
21. Javid B, MacAry PA, Lehner PJ. Structure and function: heat shock proteins and adaptive immunity. J Immunol 2007;179:2035-40.
22. Byun J, Logothetis CJ, Gorlov IP. Housekeeping genes in prostate tumorigenesis. Int J Cancer 2009;125:2603-8.
23. Kirshner JR, He S, Balasubramanyam V, Kepros J, Yang CY, Zhang M. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther 2008;7:2319-27.
24. Sumbayev VV, Yasinska IM. Role of MAP kinase-dependent apoptotic pathway in innate immune responses and viral infection. Scand J Immunol 2006;63:391-400.
25. Waterman M. Expression of lymphoid enhancer factor/T-cell factor proteins in colon cancer. Curr Opin Gastroenterol 2002;18:53-9.
26. Cronauer MV, Schulz WA, Ackermann R, Burchardt M. Effects of WNT/β-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines. Int J Oncol 2005;26:1033-40.
27. Waterman M. Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev 2004;23:41-52.
28. He TC, Sparks AB, Rago C, et al. Identification of c-myc as a target of the APC pathway. Science 1998;281:1509-12.
29. Chen S, Guttridge DC, You Z, et al. Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription. J Cell Biol 2001;152:87-96.
30. Sancho D, Gómez M, Sánchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005;26:136-40.
31. Nie F, Zhang X, Qi Q, et al. Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells. Toxicology 2009;260:60-7.
32. Zhai D, Jin C, Shiau CW, Kitada S, Satterthwait AC, Reed JC. Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins. Mol Cancer Ther 2008;7:1639-46.
33. Rong JJ, Hu R, Song XM, et al. Gambogic acid triggers DNA damage signaling that induces p53/p21(Waf1/CIP1) activation through the ATR-Chk1 pathway. Cancer Lett 2010;296:55-64.
34. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;421:499-506.
35. Olive PL, Banáth JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 2006;1:23-9.
36. Lieberman HB. DNA damage repair and response proteins as targets for cancer therapy. Curr Med Chem 2008;15:360-7.
37. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Moreno-Sánchez R. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med 2010;31:29-59.
38. Ralph SJ, Neuzil J. Mitochondria as targets for cancer therapy. Mol Nutr Food Res 2009;53:9-28.
39. Khurana D, Arneson LN, Schoon RA, Dick CJ, Leibson PJ. Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk. J Immunol 2007;178:3575-82.
40. Gu H, You Q, Liu W, et al. Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice. Int Immunopharmacol 2008;8:1493-502.